Ironwood Pharmaceuticals (IRWD) Tax Provisions (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 9 years of Tax Provisions data on file, last reported at $24.4 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 2090.31% year-over-year to $24.4 million; the trailing twelve-month figure through Mar 2026 stood at $69.3 million (up 1128.04% YoY), and the FY2025 full-year result was $46.0 million, up 235.96% from the prior year.
• Tax Provisions improved to $24.4 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $27.9 million in Q3 2025 to a low of -$54.2 million in Q4 2022.
• A 5-year average of $5.0 million and a median of $14.2 million in 2025 frame the typical range for Tax Provisions.
• Peak annual rise in Tax Provisions reached 4316.0% in 2022, while the deepest fall reached 1213.49% in 2022.
• Tracing IRWD's Tax Provisions over 5 years: stood at -$54.2 million in 2022, then grew by 6.58% to -$50.7 million in 2023, then jumped by 42.96% to -$28.9 million in 2024, then jumped by 109.42% to $2.7 million in 2025, then soared by 796.07% to $24.4 million in 2026.
• Business Quant data shows IRWD's Tax Provisions at $24.4 million in Q1 2026, $2.7 million in Q4 2025, and $27.9 million in Q3 2025.